181 related articles for article (PubMed ID: 37200033)
1. Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease.
Harris KM; Preiss L; Varughese T; Bauer A; Calhoun CL; Treadwell M; Masese R; Hankins JS; Hussain FA; Glassberg J; Melvin CL; Gibson R; King AA;
JAMA Netw Open; 2023 May; 6(5):e2314070. PubMed ID: 37200033
[TBL] [Abstract][Full Text] [Related]
2. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936
[TBL] [Abstract][Full Text] [Related]
5. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet JB; Colombatti R; de Montalembert M; Jain S; Jastaniah W; Nur E; Pita M; DeBonnett L; Ramscar N; Bailey T; Rajkovic-Hooley O; James J
Am J Hematol; 2021 Apr; 96(4):404-417. PubMed ID: 33264445
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
[TBL] [Abstract][Full Text] [Related]
8. Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.
Masese RV; Bulgin D; Knisely MR; Preiss L; Stevenson E; Hankins JS; Treadwell MJ; King AA; Gordeuk VR; Kanter J; Gibson R; Glassberg JA; Tanabe P; Shah N;
PLoS One; 2021; 16(10):e0258638. PubMed ID: 34714833
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
Knisely MR; Pugh N; Kroner B; Masese R; Gordeuk V; King AA; Smith SM; Gurney JG; Adams R; Wun T; Snyder A; Glassberg J; Shah N; Treadwell M;
Am J Hematol; 2020 Sep; 95(9):1066-1074. PubMed ID: 32449965
[TBL] [Abstract][Full Text] [Related]
10. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
[TBL] [Abstract][Full Text] [Related]
11. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
13. Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease.
Forté S; Blais F; Castonguay M; Fadiga N; Fortier-St-Pierre M; Couette M; Ward R; Béland S; Cohn M; Soulières D; Kuo KHM
JAMA Netw Open; 2021 May; 4(5):e217039. PubMed ID: 33983401
[TBL] [Abstract][Full Text] [Related]
14. Severe Pain Profiles and Associated Sociodemographic and Clinical Characteristics in Individuals With Sickle Cell Disease.
Knisely MR; Tanabe PJ; Yang Q; Masese R; Jiang M; Shah NR
Clin J Pain; 2021 Sep; 37(9):669-677. PubMed ID: 34265788
[TBL] [Abstract][Full Text] [Related]
15. Association between Participants' Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease.
Badawy SM; Barrera L; Cai S; Thompson AA
Biomed Res Int; 2018; 2018():8296139. PubMed ID: 30105252
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Hydroxyurea and Patients' Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study.
Madkhali MA; Abusageah F; Hakami F; Zogel B; Hakami KM; Alfaifi S; Alhazmi E; Zaalah S; Trabi S; Alhazmi AH; Mohrag M; Malhan H
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256385
[No Abstract] [Full Text] [Related]
17. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
[TBL] [Abstract][Full Text] [Related]
18. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.
Alberts NM; Badawy SM; Hodges J; Estepp JH; Nwosu C; Khan H; Smeltzer MP; Homayouni R; Norell S; Klesges L; Porter JS; Hankins JS
JMIR Mhealth Uhealth; 2020 May; 8(5):e14884. PubMed ID: 32383683
[TBL] [Abstract][Full Text] [Related]
19. Biopsychosocial Factors Associated With Pain and Pain-Related Outcomes in Adults and Children With Sickle Cell Disease: A Multivariable Analysis of the GRNDaD Multicenter Registry.
Kenney MO; Wilson S; Shah N; Bortsov A; Smith WR; Little J; Lanzkron S; Kanter J; Padrino S; Owusu-Ansah A; Cohen A; Desai P; Manwani D; Rehman SSU; Hagar W; Keefe F
J Pain; 2024 Jan; 25(1):153-164. PubMed ID: 37544393
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
